Le Lézard
Classified in: Health, Science and technology
Subject: PDT

Stayhealthy and OncoGambit Release Mobile Coaching Platform to Support Breast Cancer Survivors and Promote Healthy Behaviors for Cancer Prevention

MONROVIA, Calif., Dec. 10, 2019 /PRNewswire-PRWeb/ -- Stayhealthy, the first company to combine patented healthcare solutions with augmented reality technology, and OncoGambit, the first computer-aided individualized cancer treatment confirmation resource, announced today the launch of a new mobile platform dedicated to assisting cancer survivors to adopt healthy lifestyle changes. The platform will be introduced at the San Antonio Breast Cancer Symposium on December 11.

"With over 3.8 million breast cancer survivors in the U.S., the need addressed by the OWL platform could not be timelier," said Dr. Colin Hill, Stayhealthy's COO and Chief Science Officer. "Current available support services are often insufficient to meet this growing need."

"Cancer survivors need ongoing guidance and support after cancer diagnosis to achieve their best outcome," stated Dr. Hannah Luu, CEO and founder of OncoGambit. "With the most advanced resources and tools, OWL provides a unique after-care support plan for ongoing support in addition to recurrence prevention."

"Almost 60% of all cancer survivors suffer from excess body fat," added John Collins, CEO of Stayhealthy. "We know from research that there is a 30% increased risk of disease recurrence and death from breast cancer related to excess body fat. OWL was also developed specifically to help survivors deal with this growing problem."

The OWL app is a game changer that is positioned as an easily accessible, comprehensive survival care guide for cancer survivors. The app uses a chatbot navigation tool to guide users through a series questions and answers spreading over four modules including education (with an emphasis on breast cancer education in treatment and cancer recurrence prevention), daily activity and movement plan, conscious eating coach, and mindfulness practice?all allowing for real time interaction with the user.

The addition of augmented reality experiences adds a powerful dimension to amplifying the platform's rich content. Approximately 23,000 oncologists are currently responsible for nearly 17 million cancer survivors in the U.S. and studies show that 80% of these survivors rely on their oncologist for nutrition, exercise, and psycho-social guidance. While initially focused on breast cancer survivors, OWL will eventually address and promote healthy behaviors for the prevention of all cancers in future versions.


SOURCE Stayhealthy INC

These press releases may also interest you

at 03:35
? The global DNA sequencing market size is expected to reach USD 11.2 billion by 2027, expanding at a CAGR of 11.4%, according to a new report by Grand View Research, Inc. The incorporation of Artificial Intelligence (AI) has increased the utility of...

at 03:32
Yardi® was recently recognized by an organization of major Asia Pacific REITs for its leading real estate technology. The 7th annual gathering of the REITS Asia Pacific conference was held virtually this year due to the COVID-19 pandemic.     The...

at 03:30
A new study has found that monitoring pain response levels during surgery with NOL technology (Medasense, Ramat Gan, Israel) can help reduce postoperative pain. Exploring the potential use of NOL monitoring to help enhance recovery after surgery, the...

at 03:25
WaterField Designs?a San Francisco manufacturer of custom laptop sleeves, bags, and cases for digital gear?introduces the custom-fit Dash Sleeve for the standard and 10-key Apple Magic Keyboard and for the Magic Trackpad 2. VIDEO DEMO Enveloped in...

at 03:15
Epson America, Inc. today introduced the Epson WorkForce® EC-C7000, the affordable color A3 multifunction printer designed for reliability and to deliver fast, professional-quality prints up to 13" x 19". Engineered to meet the needs of today's...

at 03:06
Immunovia, a diagnostic company that develops highly accurate blood tests for the early detection of cancer and autoimmune diseases, today announced positive results from the verification study and will now commence the validation study, the last...

News published on 10 december 2019 at 11:00 and distributed by: